Interestingly, Cd9 gene targeting abrogated expression of CD44 in PECs both in crescentic GN and FSGS models, suggesting that de novo expression of CD9, is a requirement for further CD44 expression and formation of extracapillary lesions (Lazareth et al. 2019). The gene discussed is CD9; the disease is ganglioneuroma.